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hybrid) (CBP) and Coleus blumei (mix colour hybrid) (CBMC). The quantities of total antioxidants in 
different parts (stems, petioles and leaves) of the plants were also evaluated. Fresh CAL samples were 
randomly collected from Jakarta, Indonesia and samples of CBR and CBMC were randomly collected 
from Kuantan, Malaysia. Samples were freeze-dried, ground and extracted using methanol. The 
antioxidants content of the extracted samples were measured on the basis of scavenging activity of the 
stable 1,1-diphenyl-2-picrylhydrazyl (DPPH) free radical (DPPH radical-scavenging assay). Ascorbic 
acid and butylated hydroxyl anisole (BHA) were used as positive control. Absorbance at 517 nm was 
determined after 30 min, and the percent inhibition activity was then calculated. Results showed that the 
total antioxidants content in CBR and CBMC were significantly higher (P<0.05) than in CAL but there 
was no significant difference (P>0.05) of total antioxidants content in CBR and CBMC. Different parts of 
CAL have the same (P>0.05) amounts of total antioxidants content. In CBP and CBMC, the leaves have 
the highest (P<0.05) content of the total antioxidants followed by petioles and stems. Coleus blumei 
showed greater amount of total antioxidants content compared to Coleus amboinicus Lour. The study 
showed the potential of Coleus spp. from Malaysia to be developed as natural functional food.. 
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The combined elevation of tumor markers carbohydrate antigen 19-9 (CA 19-9) and carbohydrate 
antigen 125 (CA 125) has been shown to be associated with the severity of liver fibrosis in patients with 
liver disease. We assessed the association between CA 19-9 and viral hepatitis B activity which will allow 
us to know the usefulness of CA 19-9 as a surrogate marker for the disease activity in hepatitis B patients.   
Methods: A prospective study involving 60 patients with hepatitis B surface antigen positive carrier 
was performed. These patients were divided into 2 groups according to HBeAg positivity. Tumor marker 
CA 19-9 was determined using routine laboratory methods and correlated with the disease activity by 
measuring hepatitis B viral DNA (HBV DNA) and serum alanine transaminase (ALT) and aspartate 
transaminase (AST) levels.  
Results: Eleven (18%) were HBeAg positive and 49 (82%) were HBeAg negative. The mean (standard 
deviation) age in the former group was 40.7 (11.7) years and in the latter group was 40.8 (12.5) years (p = 
0.98). There was no significance difference between the two groups with respect to the levels of serum 
ALT/AST, HBV DNA and CA 19-9. There was no significant correlation seen between CA 19-9 and 
serum ALT/AST. It was the same with the levels of HBV DNA.   
Discussions and conclusion: The use of CA 19-9 as a non-invasive marker for disease activity in 
patients with hepatitis B infection was not useful. There was no role of CA 19-9 in hepatitis B patients to 
assess the disease activity.   
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Background – We undertook a prospective longitudinal study of patients with end-stage faecal 
incontinence who underwent gracilis muscle transposition as a neo-anal sphincter with external low 
frequency electrical stimulation of the nerve to gracilis combined with biofeedback.  
Method – 31 Patients (21 male, 10 female: median age 22 years, range – 4 to 77) with end stage faecal 
incontinence were operated for traumatic disruption (11-35%), congenital atresia (11-35%), iatrogenic 
injury (6-20%) and perineal sepsis (3-10%). Assessment of outcome was clinical, anal manometry 
(maximum resting –MRP and maximum squeeze pressures MSP), the Cleveland continence score (CCS) 
and the Rockwood quality of life scale (FIQL).  
